Drug Patent Watch

JUNE 28, 2022

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier. There are seven….

Branding 97

Branding Drugs Marketing 97

Drug Channels

APRIL 12, 2024

To learn more about enhancing patient engagement and adherence, download CareMetx's new report: Driving Brand Success: Minimize Risk and Capture Missed Value from Patient Engagement and Adherence. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Jessica’s insights.

Branding 88

Branding Manufacturing Drugs 88

Drug Patent Watch

JULY 1, 2022

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers. There are….

Branding 97

Branding Drugs Marketing 97

Drug Patent Watch

SEPTEMBER 11, 2023

Annual Drug Patent Expirations for PROAIR+HFA Proair Hfa is a drug marketed by Teva Branded Pharm and is included in one NDA. There are… The post New patent expiration for Teva Branded drug PROAIR HFA appeared first on DrugPatentWatch - Make Better Decisions. It is available from five suppliers.

Branding 59

Branding Drugs Marketing 59

Drug Patent Watch

DECEMBER 9, 2021

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers. There are….

Branding 98

Branding Drugs Marketing 98

Drug Patent Watch

JUNE 20, 2023

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. There are nine… The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

JUNE 8, 2023

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. There are nine… The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

JUNE 6, 2023

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. There are nine… The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

MARCH 10, 2022

DrugPatentWatch developed this course to help users better understand the complexities and common strategies around brand erosion and generic entry. The post Free Online Course on Drug Patents, Generic and Branded Drugs appeared first on DrugPatentWatch - Make Better Decisions.

Branding 115

Branding Drugs Development 115

Drug Patent Watch

JUNE 22, 2023

Annual Drug Patent Expirations for LOSEASONIQUE Loseasonique is a drug marketed by Teva Branded Pharm and is included in one NDA. There are three… The post New patent expiration for Teva Branded drug LOSEASONIQUE appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers.

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

JUNE 22, 2023

Annual Drug Patent Expirations for SEASONIQUE Seasonique is a drug marketed by Teva Branded Pharm and is included in one NDA. There are four… The post New patent expiration for Teva Branded drug SEASONIQUE appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers.

Branding 52

Branding Drugs Marketing 52

Fierce Pharma

OCTOBER 17, 2023

drug pricing tensions continue to flare overseas. working to tweak the Statutory Scheme for branded medicines, the Association of the British Pharmaceutical Industry is making its discontent known—and it’s managed to rally more than 20 major drugmakers to its cause. With the U.K.

Branding 85

Branding Drugs Marketing Medicine 85

Drug Patent Watch

JUNE 14, 2023

Annual Drug Patent Expirations for LOSEASONIQUE Loseasonique is a drug marketed by Teva Branded Pharm and is included in one NDA. There are three… The post New patent expiration for Teva Branded drug LOSEASONIQUE appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers.

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

JUNE 14, 2023

Annual Drug Patent Expirations for SEASONIQUE Seasonique is a drug marketed by Teva Branded Pharm and is included in one NDA. There are four… The post New patent expiration for Teva Branded drug SEASONIQUE appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers.

Branding 52

Branding Drugs Marketing 52

Bio Pharma Dive

AUGUST 10, 2023

The drug, which will be sold under the brand name Talvey, is now cleared by the FDA to treat multiple myeloma, a blood cancer that J&J has identified as a research priority.

Drugs 245

Drugs Branding Research 245

Bio Pharma Dive

MARCH 14, 2023

Responding to policy changes and pressure over high drug costs, the pharma is reducing the sticker price of four branded diabetes medicines by up to 75%.

Insulin 280

Insulin Drugs Branding Medicine 280

Medical Xpress

APRIL 19, 2023

Researchers from Johns Hopkins University published a new Journal of Marketing article that examines how receiving negative medical results might affect how people choose between generic and brand name drugs.

Branding 95

Branding Drugs Marketing Research 95

Drug Patent Watch

FEBRUARY 16, 2023

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. There are nine… The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Branding 52

Branding Drugs Marketing 52

Bio Pharma Dive

MAY 13, 2022

Tirzepatide, now branded as Mounjaro, helped improve blood sugar control in testing and has been shown to have powerful weight loss effects as well, making it one of the most closely watched drugs in Lilly's pipeline.

FDA Approval 352

FDA Approval Drugs Branding 352

Drug Channels

DECEMBER 5, 2023

Consider two apparently unrelated drug channel anomalies: In McKesson’s 2023 fiscal year, CVS bought $75 billion in pharmaceuticals from McKesson’s wholesale business—a jump of more than 35% compared with the previous year. Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription.

Pharmacy 83

Pharmacy Branding Drugs Sales 83

Drug Channels

JANUARY 4, 2023

Time for the Drug Channels annual reality check on drug pricing. For 2022, brand-name drugs’ net prices dropped for an unprecedented fifth consecutive year. What’s more, after adjusting for overall inflation, brand-name drug net prices plunged by almost 9%. d/b/a Drug Channels Institute.

Branding 95

Branding Drugs 95

Drug Patent Watch

FEBRUARY 20, 2023

Annual Drug Patent Expirations for ZECUITY Zecuity is a drug marketed by Teva Branded Pharm and is included in one NDA. There are ten patents protecting this drug. This drug… The post New patent expiration for Teva Branded drug ZECUITY appeared first on DrugPatentWatch - Make Better Decisions.

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

MAY 5, 2023

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. There are… The post New patent expiration for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

MAY 5, 2023

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. There are… The post New patent expiration for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

JUNE 22, 2021

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent expiration for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers.

Branding 88

Branding Drugs Marketing 88

Drug Patent Watch

OCTOBER 17, 2022

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier. There are eight….

Branding 52

Branding Drugs Marketing 52

Pharma Marketing Network

JULY 19, 2023

Sponsorships can be a powerful way for businesses to connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. But in order to be truly effective, sponsorships must be aligned with a company’s brand values.

Branding 98

Branding Drugs Research Marketing 98

pharmaphorum

APRIL 30, 2024

California will start selling its own generic of overdose reversal agent naloxone in another example of the use of government-level purchasing power to reduce drug prices

Branding 105

Branding Drugs 105

Drug Patent Watch

NOVEMBER 14, 2022

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers. There are….

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

NOVEMBER 14, 2022

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers. There are….

Branding 52

Branding Drugs Marketing 52

STAT News

APRIL 4, 2023

For the first time, Mark Cuban’s Cost Plus Drug Company is selling medicines made by a large drug manufacturer directly to consumers at a greatly reduced price, the latest sign that the billionaire is trying to make good on his vow to disrupt the opaque pharmaceutical supply chain. The average retail price is $676.14.

Branding 140

Branding Medicine Manufacturing Drugs 140

Drug Patent Watch

OCTOBER 7, 2022

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers. There are….

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

OCTOBER 7, 2022

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers. There are….

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

AUGUST 24, 2022

Annual Drug Patent Expirations for QVAR+80 Qvar 80 is a drug marketed by Teva Branded Pharm and is included in one NDA. There are seven patents protecting this drug. The post New patent for Teva Branded drug QVAR 80 appeared first on DrugPatentWatch - Make Better Decisions.

Branding 52

Branding Drugs Marketing 52

Drug Patent Watch

JUNE 14, 2021

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers. There are….

Branding 72

Branding Drugs Marketing 72

Drug Patent Watch

JUNE 14, 2021

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions. It is available from two suppliers. There are….

Branding 72

Branding Drugs Marketing 72

Drug Patent Watch

AUGUST 24, 2022

Annual Drug Patent Expirations for PROAIR+HFA Proair Hfa is a drug marketed by Teva Branded Pharm and is included in one NDA. The post New patent for Teva Branded drug PROAIR HFA appeared first on DrugPatentWatch - Make Better Decisions. It is available from nine suppliers. There are….

Branding 52

Branding Drugs Marketing 52